BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  FDA Roundup: December 13, 2024

  December 16, 2024

   · 

  2 min read
• Press Releases

  Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules

  December 16, 2024

   · 

  6 min read
• Press Releases

  BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

  December 16, 2024

   · 

  3 min read
• Press Releases

  TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  2 min read
• Press Releases

  Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth

  December 16, 2024

   · 

  6 min read
• Press Releases

  Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  3 min read
• Press Releases

  Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  4 min read
• Press Releases

  Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  2 min read
• Press Releases

  Edesa Biotech Reports Fiscal Year 2024 Results

  December 16, 2024

   · 

  9 min read
• Press Releases

  Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

  December 16, 2024

   · 

  14 min read